logo
Select company
Select metric
3.99%Capital Expenditures Margin
VS
Market
42
Sector
42
Industry
48
History
88
$ 6.18Close
$ 3 - $ 24 52-Week Range
Ticker Information

Ticker

GBIO

Company Name

GENERATION BIO CO

Sector

Healthcare

Industry

Biotechnology

Exchange

NASDAQ

GENERATION BIO CO - Capital Expenditures Margin Chart Analysis (TTM)

From
Zoom
1Y
3Y
5Y
10Y

GBIO - CapEx % Historical data
DateCapital ExpenditureCapital Expenditures MarginRevenues
6/30/2025$ 848K3.99%$ 21.23M
3/31/2025$ 503K2.05%$ 24.56M
12/31/2024$ 2.21M11.08%$ 19.89M
9/30/2024$ 6.45M34.73%$ 18.58M
6/30/2024$ 7.02M53.27%$ 13.17M
3/31/2024$ 8.56M85.92%$ 9.96M
12/31/2023$ 7.4M125.29%$ 5.9M
9/30/2023$ 3.5M115.63%$ 3.03M
6/30/2023$ 3.54M402.27%$ 880K
3/31/2023$ 6.77M0%$ 0
Previous (option currently disabled)
1 (current)
Next (option currently disabled)

Key Performance Insights, Last 5 Years

  • GENERATION BIO CO's latest trailing twelve months (TTM) CapEx % stands at 0%.
  • Over the past 5 years, GENERATION BIO CO's average CapEx % has been 92.69%.
  • The median CapEx % for GENERATION BIO CO during this period was 53.27%
  • GENERATION BIO CO reached its highest CapEx % over the past 5 years at 402.27%.
  • The lowest CapEx % recorded by GENERATION BIO CO in the same timeframe 2.05%

GENERATION BIO CO's CapEx % vs. competitors

We picked the following companies as peers based on multiple factors, including sector, industry, market capitalization and revenue

CapEx % Benchmarks
CompanyCapEx %
XLO : XILIO THERAPEUTICS INC 2.92%BCAB : BIOATLA INC -CRIS : CURIS INC -PRPO : PRECIPIO INC 1.65%MRSN : MERSANA THERAPEUTICS INC -DYAI : DYADIC INTERNATIONAL INC -XFOR : X4 PHARMACEUTICALS INC 9.56%NEPH : NEPHROS INC -POCI : PRECISION OPTICS CORPORATION INC 1.19%NRXS : NEURAXIS INC 0.92%

Definition of Capital Expenditures Margin

[Calculation] The CapEx Margin, also named Capex to Revenue Ratio, measures how much of a company’s revenue is reinvested into productive [Assets]. It is capital expenditures [CapEx] divided by [Revenue].
CapEx / Revenues
(=) CapEx %
CapEx % for GENERATION BIO CO is calculated as follows: CapEx [ $ 5.52M ] / Revenues [ $ 0 ]
(=) CapEx % [ 0% ]

GBIO - Capital Expenditures Margin, Last 5 years

2.05%

Minimum

Mar 31, 2025

402.27%

Maximum

Jun 30, 2023

92.69%

Average

53.27%

Median

CapEx % Benchmark Analysis

The chart above depicts the distribution of CapEx % for companies in the Total Stock Market. The average CapEx % of the companies is 3.46% with a standard deviation of 3.27%.
The following table provides additional summary stats:
CapEx % in the Market:
filtered constituents2.85K
min0%
max15.04%
average3.46%
median2.43%
std3.27%